.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Expert Perspectives: Management of Acute Myeloid Leukemia

EP. 1: Pathobiology of Acute Myeloid Leukemias (AML)

January 7th 2016

EP. 2: Development of Secondary Acute Myeloid Leukemias

January 7th 2016

EP. 3: Risk Stratification of Myelodysplastic Syndromes and AML

January 7th 2016

EP. 4: Prognostic Factors in Acute Myeloid Leukemia

January 7th 2016

EP. 5: Prognostic Factors in Acute Myeloid Leukemia Treatment

January 7th 2016

EP. 6: Evolution in Acute Myeloid Leukemia Induction Strategies

January 7th 2016

EP. 7: Consolidation Strategies in AML Treatment

January 7th 2016

EP. 8: Management of Primary Refractory AML

January 7th 2016

EP. 9: Emerging Therapeutic Approaches in AML

January 7th 2016

EP. 10: Immunotherapy in Acute Myeloid Leukemia

January 7th 2016

EP. 11: The Importance of Supportive Care in AML

January 7th 2016

EP. 12: Infection Prophylaxis in Acute Myeloid Leukemia

January 7th 2016

EP. 13: Multidisciplinary Team in Acute Myeloid Leukemia

January 7th 2016